Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 3898

Sort by

Sort Order Select

Journal Articles

Pooled CAR-T screening in nonhuman primates identifies designs with enhanced proliferation, trafficking, and persistence

Blood blood.2025028683.

https://doi.org/10.1182/blood.2025028683

Published: 2025

Includes: Supplemental data

Journal Articles

Outcomes of PLAT-02 and PLAT-03: evaluating CD19 CAR T-cell therapy and CD19-expressing T-APC support in pediatric B-ALL

Colleen Annesley, Kristy Seidel, Qian Wu, Corinne Summers, Alan S. Wayne, Michael A. Pulsipher, Anurag K. Agrawal, Chris T. Brown, Stephanie Mgebroff, Catherine Lindgren, Stephanie Rawlings-Rhea, Wenjun Huang, Ashley L. Wilson, Michael C. Jensen, Julie R. Park, Rebecca A. Gardner

Blood (2025) 146 (7): 789–801.

https://doi.org/10.1182/blood.2025028359

Published: 2025

Includes: Supplemental data

Journal Articles

T-ICAHT: grading and prognostic impact of thrombocytopenia after CAR T-cell therapy

Blood (2025) 146 (7): 834–846.

https://doi.org/10.1182/blood.2025028833

Published: 2025

Includes: Supplemental data

Journal Articles

Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR T cells

Blood (2025) 146 (7): 819–833.

https://doi.org/10.1182/blood.2024025536

Published: 2025

Includes: Supplemental data

Journal Articles

HPA-1a antibodies in FNAIT do not distinguish αvβ3 from αIIbβ3 and bind inactive integrins more strongly than active integrins

Janita Oosterhoff, Wendy Stam, Suze Rosanne van Brummelen, Arthur Bentlage, Thijs de Vos, Jose Maria de Pereda, Leendert Porcelijn, Rick Kapur, Masja De Haas, C Ellen van der Schoot, Gestur Vidarsson, Coert Margadant

Blood blood.2025029618.

https://doi.org/10.1182/blood.2025029618

Published: 2025

Includes: Supplemental data

Journal Articles

Inhibition of terminal complement complex formation alleviates murine antibody-mediated TRALI

Dawei Chen, Huaqin Liang, Xiuzhang Xu, Wenjie Xia, Xin Ye, Yalin Luo, Jiansen He, Yaori Xu, Jing Liu, Hui Ren, Shengxue Luo, Trent M. Woodruff, Wioleta M. Zelek, B. Paul Morgan, Rick Kapur, Sentot Santoso, Yongshui Fu

Blood (2025) 146 (6): 759–764.

https://doi.org/10.1182/blood.2024028012

Published: 2025

Includes: Supplemental data

Journal Articles

Deciphering neutrophil dynamics in the focal lesion tumor microenvironment to overcome immunosuppression in multiple myeloma

Joshua Rivera, Qi Yan, Saeed Daneshmandi, Romain Lannes, Eriko Katsuta, Jee Eun Choi, Prashant K. Singh, Ahmed Belal, Ronald Alberico, Ian Lund, Magan Schaefer, Hamza Hassan, Sarah Parker, Kenneth C. Anderson, Nikhil C. Munshi, Mehmet K. Samur, Philip L. McCarthy, Jens Hillengass, Hemn Mohammadpour

Blood blood.2025028963.

https://doi.org/10.1182/blood.2025028963

Published: 2025

Includes: Supplemental data

Journal Articles

Preclinical advances in glofitamab combinations: a new frontier for non-Hodgkin lymphoma

Blood blood.2025028863.

https://doi.org/10.1182/blood.2025028863

Published: 2025

Includes: Supplemental data

Journal Articles

Sequential Targeting in Multiple Myeloma: Talquetamab, a GPRC5D bispecific antibody, as a Bridge to BCMA CAR-T cell therapy

Blood blood.2025029773.

https://doi.org/10.1182/blood.2025029773

Published: 2025

Includes: Supplemental data

Journal Articles

A phase 1 trial of fully human BCMA CAR-T therapy for relapsed/refractory multiple myeloma with 5-year follow-up

Blood (2025) 146 (5): 535–545.

https://doi.org/10.1182/blood.2024027681

Published: 2025

Includes: Supplemental data

Journal Articles

Modeling the HLH immune synapse uncovers critical roles for IS termination, cytokine intensity, and target cell death

Anastasia Frank-Kamenetskii, Hannah Klinghoffer, Jemy Varghese, Vinh Dang, Jeremy Morrissette, Joseph A. Fraietta, Caroline Diorio, Janis K. Burkhardt, Scott W. Canna

Blood (2025) 146 (5): 558–570.

https://doi.org/10.1182/blood.2024027179

Published: 2025

Includes: Multimedia, Supplemental data

Journal Articles

Ruxolitinib targets JAK-STAT signaling to modulate neutrophil activation in refractory macrophage activation syndrome

Blood (2025) 146 (5): 612–627.

https://doi.org/10.1182/blood.2024024362

Published: 2025

Includes: Supplemental data

Journal Articles

Safety and Efficacy of Elranatamab in Patients with Relapsed and/or Refractory immunoglobulin Light-Chain Amyloidosis

Pedro Vianna, Rajshekhar Chakraborty, Shahrier Hossain, Divaya Bhutani, Shannon Miller, Annemarie Rossi, Sarah AM Cuddy, Rodney H Falk, Suzanne Lentzsch, Jacob Laubach, Giada Bianchi

Blood blood.2025028383.

https://doi.org/10.1182/blood.2025028383

Published: 2025

Includes: Supplemental data

Journal Articles

NKG2D-mediated cytotoxicity of CD4 cytotoxic T cells in multiple myeloma

Blood (2025) 146 (4): 456–470.

https://doi.org/10.1182/blood.2024025875

Published: 2025

Includes: Supplemental data

Journal Articles

Relationship between immunogenicity and protein structure at amino acid substitution sites of blood group antigens

John G. Howe, Gary Stack

Blood (2025) 146 (4): 504–517.

https://doi.org/10.1182/blood.2024025071

Published: 2025

Includes: Supplemental data

Journal Articles

Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia

Sara K. Silbert, Alexander W. Rankin, Chloe N. Hoang, Alexandra Semchenkova, Regina M. Myers, Elena Zerkalenkova, Hao-Wei Wang, Alexandra E. Kovach, Constance M. Yuan, Dana Delgado Colon, Loïc Vasseur, Alex Bataller, Samuel John, Kaylyn Utley Lyons, Barbara Friedes, Anna Alonso-Saladrigues, Hisham Abdel-Azim, Estelle Balducci, Ahmed Assim Aljudi, Marie Balsat, D. Nathan Biery, Aghiad Chamdin, Bill H. Chang, Raymund S. Cuevo, Barbara De Moerloose, David S. Dickens, Ulrich Duffner, Nicolas Duployez, Firas El Chaer, Michelle Ann Elliott, Gabriele Escherich, Sneha Fernandes, Mandi R. Fitzjohn, Zhubin Gahvari, Stephan A. Grupp, Rui Rochelle He, Cynthia Harrison, Christopher B. Hergott, Emily M. Hsieh, Annette S. Kim, Dennis J. Kuo, Daniel P. Larson, Benjamin J. Lee, Thibaut Leguay, R. Coleman Lindsley, Abhishek A. Mangaonkar, Kerstin Mezger, Holly L. Pacenta, Jing Pan, Marlie Provost, Latika Puri, Sunil S. Raikar, Armando Martinez, Isabella Bristol, Kyle Murphy, Lauren Reiman, Michele Redell, Kelly Reed, Gabrielle Roth-Guepin, Jeremy Rubinstein, Süreyya Savaşan, Kristian Schafernak, Alexandra Stevens, Aimee Talleur, Naomi Torres Carapia, Jacques Vargaftig, Anant Vatsayan, Matthias Wölfl, Liping Zhao, Susana Rives, Vanessa A. Fabrizio, Koji Sasaki, Ibrahim Aldoss, Nicolas Boissel, Susan R. Rheingold, Kara L. Davis, Sara Ghorashian, Elad Jacoby, Alexander Popov, Adam J. Lamble, Nirali N. Shah

Blood (2025) 146 (4): 437–455.

https://doi.org/10.1182/blood.2024026655

Published: 2025

Includes: Supplemental data

Journal Articles

Itacitinib for the prevention of IEC therapy–associated CRS: results from the 2-part phase 2 INCB 39110-211 study

Matthew J. Frigault, Richard T. Maziarz, Jae H. Park, Aleksandr Lazaryan, Nirav N. Shah, Jakub Svoboda, Lazaros Lekakis, Ran Reshef, Christine L. Phillips, Lea Burke, Jing Lei, Michael Pratta, Rodica Morariu-Zamfir, John F. DiPersio

Blood (2025) 146 (4): 422–436.

https://doi.org/10.1182/blood.2024026586

Published: 2025

Includes: Supplemental data

Journal Articles

Inflammasome-resistant IPSC-derived myeloid-derived suppressor cells ameliorate xenogeneic graft-versus-host disease

Blood blood.2025028562.

https://doi.org/10.1182/blood.2025028562

Published: 2025

Includes: Supplemental data

Journal Articles

A BCMA-mRNA vaccine is a promising therapeutic for multiple myeloma

Debasmita Dutta, Jiye Liu, Kenneth Wen, Arghya Ray, Alessandro Salatino, Xiangdong Liu, Annamaria Gulla, Teru Hideshima, Yan Song, Kenneth C. Anderson

Blood blood.2025028597.

https://doi.org/10.1182/blood.2025028597

Published: 2025

Includes: Supplemental data

Journal Articles

Blunted CD40-responsive enhancer activation in CREBBP -mutant lymphomas can be restored by enforced CD4 T-cell engagement

Blood (2025) 146 (2): 191–205.

https://doi.org/10.1182/blood.2024026664

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Pooled CAR-T screening in nonhuman primates identifies designs with enhanced proliferation, trafficking, and persistence

Outcomes of PLAT-02 and PLAT-03: evaluating CD19 CAR T-cell therapy and CD19-expressing T-APC support in pediatric B-ALL

T-ICAHT: grading and prognostic impact of thrombocytopenia after CAR T-cell therapy

Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR T cells

HPA-1a antibodies in FNAIT do not distinguish αvβ3 from αIIbβ3 and bind inactive integrins more strongly than active integrins

Inhibition of terminal complement complex formation alleviates murine antibody-mediated TRALI

Deciphering neutrophil dynamics in the focal lesion tumor microenvironment to overcome immunosuppression in multiple myeloma

Preclinical advances in glofitamab combinations: a new frontier for non-Hodgkin lymphoma

Sequential Targeting in Multiple Myeloma: Talquetamab, a GPRC5D bispecific antibody, as a Bridge to BCMA CAR-T cell therapy

A phase 1 trial of fully human BCMA CAR-T therapy for relapsed/refractory multiple myeloma with 5-year follow-up

Modeling the HLH immune synapse uncovers critical roles for IS termination, cytokine intensity, and target cell death

Ruxolitinib targets JAK-STAT signaling to modulate neutrophil activation in refractory macrophage activation syndrome

Safety and Efficacy of Elranatamab in Patients with Relapsed and/or Refractory immunoglobulin Light-Chain Amyloidosis

NKG2D-mediated cytotoxicity of CD4 cytotoxic T cells in multiple myeloma

Relationship between immunogenicity and protein structure at amino acid substitution sites of blood group antigens

Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia

Itacitinib for the prevention of IEC therapy–associated CRS: results from the 2-part phase 2 INCB 39110-211 study

Inflammasome-resistant IPSC-derived myeloid-derived suppressor cells ameliorate xenogeneic graft-versus-host disease

A BCMA-mRNA vaccine is a promising therapeutic for multiple myeloma

Blunted CD40-responsive enhancer activation in CREBBP -mutant lymphomas can be restored by enforced CD4 T-cell engagement

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only